EU adopts SPC manufacturing waiver

The European Union has adopted the proposed supplementary protection certificate (SPC) manufacturing waiver, despite criticism from parts of the pharmaceutical industry.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

EC plans to lower barriers to generic drugs

25 November 2020 The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.

Big Pharma

SPC generics waiver comes into force

1 July 2019 The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.

Generics

European Council agrees on SPC manufacturing waiver

15 February 2019 The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

EU adopts SPC manufacturing waiver

More on this story

Editor's picks

Editor's picks

More features